Oscar Health Inc vs Phillips 66 — how do they compare? Oscar Health Inc trades at $28.84 (market cap $9.28B), while Phillips 66 trades at $211.8 (market cap $85.11B). The key difference: Phillips 66 is far larger — about 9.2× Oscar Health Inc's market cap, and Phillips 66 pays a 2.39% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals.
| OSCR | PSX | |
|---|---|---|
Market Cap | $9.28B | $85.11B |
Sector | Health | Energy |
52-Week High | $32.18 | $212.27 |
52-Week Low | $10.85 | $118.37 |
Enterprise Value | $4.90B | $107.08B |
Dividend Yield | — | 2.39% |
Signals from Pluang's Aura AI — not financial advice
Oscar Health (OSCR) trades at $29.60, up 1.72% with mixed technical signals showing neutral overall momentum. The company reported strong Q1 2026 earnings beat but faces profitability challenges with negative margins. Revenue growth from $11.7B in 2025 to projected $13.3B in 2026 indicates expansion, while cash flow trends show operational improvement. Analyst consensus is divided with 27% buy ratings against a $24.67 price target below current levels.
The stock presents growth potential through revenue expansion and cash flow generation, but profitability concerns and negative ROE pose significant risks. Current valuation at 0.61 P/S suggests reasonable pricing for growth, though execution on margin improvement remains critical for sustained upside.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →Phillips 66 is an independent refiner with 12 refineries that have a total crude throughput capacity of 2.0 million barrels per day, or mmb/d, after converting its 255 mb/d Alliance refinery to a terminal. The midstream segment comprises extensive transportation and NGL processing assets. It also includes its DCP Midstream joint venture, which holds 45 natural gas processing facilities, 11 NGL fractionation plants, and a natural gas pipeline system with 58,000 miles of pipeline. Its CPChem chemical joint venture operates facilities in the United States and the Middle East and primarily produces olefins and polyolefins.
Read more on PSX →